TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vitrolife AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
3,721,953
|
3,557,767
|
3,059,082 |
| Financial expenses |
138,194
|
143,851
|
112,564 |
| Earnings before taxes |
695,095
|
-3,760,374
|
507,955 |
| EBITDA |
1,166,398
|
1,131,556
|
993,208 |
| Total assets |
17,992,018
|
16,541,795
|
19,439,451 |
| Current assets |
2,430,768
|
1,938,943
|
1,487,921 |
| Current liabilities |
726,034
|
564,259
|
587,412 |
| Equity capital |
14,066,899
|
12,887,790
|
15,830,794 |
| - share capital |
28,876
|
28,365
|
26,486 |
| Employees (average) |
1,082
|
1,084
|
1,117 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
78.2%
|
77.9%
|
81.4% |
| Turnover per employee |
3,440
|
3,282
|
2,739 |
| Profit as a percentage of turnover |
18.7%
|
-105.7%
|
16.6% |
| Return on assets (ROA) |
4.6%
|
-21.9%
|
3.2% |
| Current ratio |
334.8%
|
343.6%
|
253.3% |
| Return on equity (ROE) |
4.9%
|
-29.2%
|
3.2% |
| Change turnover |
100,036
|
281,623
|
1,469,188 |
| Change turnover % |
3%
|
9%
|
92% |
| Chg. No. of employees |
-2
|
-33
|
639 |
| Chg. No. of employees % |
0%
|
-3%
|
134% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.